Literature DB >> 18439953

Vestibular evoked myogenic potentials in patients with benign paroxysmal positional vertigo involving each semicircular canal.

Seok Min Hong1, Dong Choon Park, Seung Geun Yeo, Chang Il Cha.   

Abstract

PURPOSE: We have investigated vestibular evoked myogenic potentials (VEMPs) as a function of age and the involvement of each of the 3 semicircular canals in patients with benign paroxysmal positional vertigo (BPPV).
MATERIALS AND METHODS: We performed prospective assessment from January 2005 to September 2006. Vestibular evoked myogenic potential was measured in 53 patients with BPPV and 84 healthy subjects, with the latter subdivided by patient age.
RESULTS: The subgroup of healthy subjects older than 60 years showed significantly more prolonged p13 and n23 latencies and lower amplitude than the other 2 subgroups. Of the 53 patients with BPPV, 13 (24.5%) showed abnormal VEMP responses on the affected side when compared with their age-related control subgroup. There was no correlation between VEMP findings and the affected semicircular canal.
CONCLUSION: Patients with BPPV may show abnormal VEMP findings, irrespective of the involved semicircular canal, and age was associated with VEMP results suggesting degeneration of the maculae of the saccule.

Entities:  

Mesh:

Year:  2008        PMID: 18439953     DOI: 10.1016/j.amjoto.2007.07.004

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  13 in total

1.  Efficacy of cervical and ocular vestibular-evoked myogenic potentials in evaluation of benign paroxysmal positional vertigo of posterior semicircular canal.

Authors:  Niraj Kumar Singh; Kumari Apeksha
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-30       Impact factor: 2.503

2.  VEMP: An Objective Test for Diagnosing the Cases of BPPV.

Authors:  Surbhi Godha; Aparaajita Upadhyay Mundra; R K Mundra; Lokesh Bhalot; Anshu Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-02-27

3.  Vestibular Evoked Myogenic Potentials After Epleys Manoeuvre Among Individuals with Benign Paroxysmal Positional Vertigo.

Authors:  K Semmanaselvan; S S Vignesh; R Muthukumar; V Jaya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-01-29

4.  Natural course of positional down-beating nystagmus of peripheral origin.

Authors:  Jacopo Cambi; Serena Astore; Marco Mandalà; Franco Trabalzini; Daniele Nuti
Journal:  J Neurol       Date:  2013-01-05       Impact factor: 4.849

5.  Effect of aging on saccular function.

Authors:  Mehri Maleki; Zahra Jafari; Homa Zarrinkoob; Alireza Akbarzadeh Baghban
Journal:  Med J Islam Repub Iran       Date:  2014-10-22

Review 6.  Vestibular migraine: the most frequent entity of episodic vertigo.

Authors:  Marianne Dieterich; Mark Obermann; Nese Celebisoy
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

7.  Evaluation of the utricular and saccular function using oVEMPs and cVEMPs in BPPV patients.

Authors:  Hui Xu; Fa-ya Liang; Liang Chen; Xi-cheng Song; Michael Chi Fai Tong; Jiun Fong Thong; Qing-quan Zhang; Yan Sun
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-02-09

8.  Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study.

Authors:  Nadja F Bednarczuk; Angela Bonsu; Marta Casanovas Ortega; Anne-Sophie Fluri; John Chan; Heiko Rust; Fabiano de Melo; Mishaal Sharif; Barry M Seemungal; John F Golding; Diego Kaski; Adolfo M Bronstein; Qadeer Arshad
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

9.  The potential role of epigenetic modulations in BPPV maneuver exercises.

Authors:  Kun-Ling Tsai; Chia-To Wang; Chia-Hua Kuo; Yuan-Yang Cheng; Hsin-I Ma; Ching-Hsia Hung; Yi-Ju Tsai; Chung-Lan Kao
Journal:  Oncotarget       Date:  2016-06-14

10.  Presence of Anxiety and Depression Symptoms Affects the First Time Treatment Efficacy and Recurrence of Benign Paroxysmal Positional Vertigo.

Authors:  Wei Wei; Zahra N Sayyid; Xiulan Ma; Tian Wang; Yaodong Dong
Journal:  Front Neurol       Date:  2018-03-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.